Tai Yi

Tropoelastin inhibits intimal hyperplasia of mouse bioresorbable arterial vascular grafts.

Benchmark dose approach for renal dysfunction in workers exposed to lead.

Application of benchmark dose for occupational epidemiology in lead exposure.

Characterization of ambient air quality during a rice straw burning episode.

Role of HO-1 in the arsenite-induced neurotoxicity in primary cultured cortical neurons.

Characterization of evolving biomechanical properties of tissue engineered vascular grafts in the arterial circulation.

Evaluation of remodeling process in small-diameter cell-free tissue-engineered arterial graft.

Comparison of the biological equivalence of two methods for isolating bone marrow mononuclear cells for fabricating tissue-engineered vascular grafts.

Well-organized neointima of large-pore poly(L-lactic acid) vascular graft coated with poly(L-lactic-co-ε-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(L-lactic acid) graft in a mouse aortic implantation model.

Biomechanical diversity despite mechanobiological stability in tissue engineered vascular grafts two years post-implantation.

The innate immune system contributes to tissue-engineered vascular graft performance.

Development of small diameter nanofiber tissue engineered arterial grafts.

Hemodynamic Characterization of a Mouse Model for Investigating the Cellular and Molecular Mechanisms of Neotissue Formation in Tissue-Engineered Heart Valves.

Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model.

A mouse model of endocardial fibroelastosis.

Interferon-γ-mediated allograft rejection exacerbates cardiovascular disease of hyperlipidemic murine transplant recipients.

Long-Term Functional Efficacy of a Novel Electrospun Poly(Glycerol Sebacate)-Based Arterial Graft in Mice.

Rational design of an improved tissue-engineered vascular graft: determining the optimal cell dose and incubation time.

TGF-β receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation.

Novel Bioresorbable Vascular Graft With Sponge-Type Scaffold as a Small-Diameter Arterial Graft.

Pilot Mouse Study of 1 mm Inner Diameter (ID) Vascular Graft Using Electrospun Poly(ester urea) Nanofibers.

Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model.

Engineered Tissue-Stent Biocomposites as Tracheal Replacements.

Fast-degrading bioresorbable arterial vascular graft with high cellular infiltration inhibits calcification of the graft.

Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.

The role of myeloid cell-derived PDGF-B in neotissue formation in a tissue-engineered vascular graft.

Deconstructing the Tissue Engineered Vascular Graft: Evaluating Scaffold Pre-Wetting, Conditioned Media Incubation, and Determining the Optimal Mononuclear Cell Source.

Intratumoral Delivery of Interferonγ-Secreting Mesenchymal Stromal Cells Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In Vivo.

Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation.

Bone marrow-derived mononuclear cell seeded bioresorbable vascular graft improves acute graft patency by inhibiting thrombus formation via platelet adhesion.

Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts.

Immuno-driven and Mechano-mediated Neotissue Formation in Tissue Engineered Vascular Grafts.

Implantation of VEGF-functionalized cell-free vascular grafts: regenerative and immunological response.

Early natural history of neotissue formation in tissue-engineered vascular grafts in a murine model.

Differential outcomes of venous and arterial tissue engineered vascular grafts highlight the importance of coupling long-term implantation studies with computational modeling.

Degradation and evaluation of polycaprolactone, poly(ε-caprolactone-co-L-lactide), and poly-L-lactic acid as scaffold sealant polymers for murine tissue-engineered vascular grafts.

Different degradation rates of nanofiber vascular grafts in small and large animal models.

Fetal Transcatheter Trileaflet Heart Valve Hemodynamics: Implications of Scaling on Valve Mechanics and Turbulence.

Electrospun Tissue-Engineered Arterial Graft Thickness Affects Long-Term Composition and Mechanics.

Effects of Braiding Parameters on Tissue Engineered Vascular Graft Development.

Tissue Engineered Vascular Graft Recipient Interleukin 10 Status Is Critical for Preventing Thrombosis.

Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering.

Imatinib attenuates neotissue formation during vascular remodeling in an arterial bioresorbable vascular graft.